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Biological activities of five synthetic lipid A analogues (D-glucosamine derivatives) were examined to 
elucidate the structure required for expression of the biological activities of endotoxin. Proclotting enzyme 
of horseshoe crab activation, interferon-inducing and tumor necrosis factor-inducing activities were 
significantly expressed by an analogue which possesses 4-0-phosphoryl, 3-0-tetradecanoyl and N-tetra- 
decanoyloxytetradecanoyl groups. The results obtained with different analogues show that the 4-0- 
phosphoryl and N-tetradecanoyloxytetradecanoyl groups are important for expression of the above 
activities. The effect of 6-0-acylation in preventing the expression of these biological activities is also 
suggested. Pyrogenic activity was not detected in any of the compounds tested. 
Synthetic lipid A analogue Limulus test Interferon-induction Tumor necrosis factor induction 
Pyrogenicity 
1. INTRODUCTION 
Most of the biological activities of endotoxin 
have been shown to be expressed by its lipid A 
moiety, and the chemical structure of lipid A has 
been proposed based on detailed investigations of 
Salmonella lipid A [ 1,2]. Chemical synthesis of the 
proposed structure has been attempted [3,4]. As a 
consequence, various synthetic lipid A analogues 
have become available and were used to elucidate 
the relationship between chemical structures and 
biological activities of lipid A. 
The authors and others have investigated the 
biological activities of synthetic lipid A analogues 
and confirmed that some analogues of D-glucos- 
amine disaccharide derivatives exhibited certain 
Abbreviations: TNF, tumor necrosis factor; CM, tetra- 
decanoyl; CM-0-(CM), (R)-3-tetradecanoyloxytetradeca- 
noyl; C&-OH, (R)-3-hydroxytetradecanoyl; CWOH, 
(R)-3-hydroxydodecanoyl 
Lipid A 
biological activities of the endotoxin [5-71, but not 
all endotoxic activities. At the same time, the im- 
portance of both phosphoryl groups and amino- 
and ester-linked acyl groups for expression of the 
biological activities was noted. 
A series of chemically synthesized erivatives of 
D-glucosamine, which are structurally related to 
the nomeducing sugar moiety of a newly proposed 
structure of lipid A [8,9], were examined here for 
proclotting enzyme of horseshoe crab activation, 
pyrogenicity and interferon- and TNF-induction. 
2. MATERIALS AND METHODS 
The structures of synthetic lipid A analogues 
[lO,l l] used are shown in fig.1. These analogues 
are the derivatives of ZV-acyl-3-O-tetradecanoyl-D- 
glucosamine with or without 4-O-phosphoryl or 
6-0-tetradecanoyl groups. ZV-Acyl groups are C14, 
Cr4-0-(Cr4), CWOH or G-OH groups. 
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Fig. 1. Structures of synthetic lipid A analogues. P, 
phosphoryl; CM, tetradecanoyl; &-OH, (R)-3- 
hydroxydodecanoyl; C14-OH, (R)3-hydroxytetra- 
decanoyl; CW0-(Cl& (R)-3+tradecanoyloxytetra- 
decanoyl. 
Compound Substituent 
no. 
RI (N-) Rz (4-O-) R3 (6-O-) 
1 c14-o-(C14) H H 
2 Cl4 P H 
3 c14-O-&14) P H 
4 &-OH P Cl4 
5 C14-OH P Cl4 
The synthetic lipid A analogues and natural lipid 
A were solubilized with triethylamine and bovine 
serum albumin prior to biological testing, and 
recovery of each preparation was determined by 
gas liquid chromatography as in [5]. 
Proclotting enzyme of horseshoe crab activa- 
tion, interferon-induction and pyrogenicity were 
assayed as in [5]. 
TNF-inducing activity [12] was assayed as 
follows: 6-week-old ICR female mice were injected 
intraperitoneally with 1.5 mg of formalin-killed 
Propionibacterium acnes. After 11 days, 10 pg of 
test sample was injected intravenously and blood 
was collected 1.5 h later from the retroorbital 
plexus. Serum was separated by centrifugation and 
incubated at 56°C for 30 min. TNF activity in the 
serum was assayed by measuring rowth inhibitory 
and cytocidal activities on L-929 cells. For growth 
inhibitory assay, lOO-fold diluted serum and 
[3H]thymidine were added to 1 x 104 L-929 cells in 
RPMI-1640 medium containing 10% fetal calf 
serum (200 pl in total volume/well of a 96 well- 
plate) and the mixture was incubated in 5% COz- 
air at 37°C for 48 h. The viable cells were 
harvested with 0.25% trypsin and 0.1% EDTA 
using a multiple cell harvester. The amount of 
[3H]thymidine incorporated into the cells was 
measured by a liquid scintillation spectrometer. 
For cytocidel assay, 40-fold diluted serum was 
used and assayed as in [ 131. 
3. RESULTS 
After solubilization, recovery of compound 1 
was about 80%. Those of the other 4 compounds 
were more than 95%. Turbidity at 660 nm of each 
preparation (200 ,ug/ml) of the compounds 1,2, 3, 
4 and 5 was 0.275, 0.010, 0.001, 0.098 and 0.129, 
respectively. As for compounds l-3, 3 prepara- 
tions of each compound were made and similar 
results were obtained. 
As shown in table 1, compounds 2 and 3 ex- 
pressed strong activity of proclotting enzyme of 
Table 1 
Proclotting enzyme of horseshoe crab activation activity of the synthetic lipid A 
analogues 
Compound Substituent LAL’ gelation at the concentration 
no. 
N- 
(ug/ml) of 
4-O- 6-O- ~ 
(RI) @2) (R3) 10 1.0 10-l 10-s 10-r 10-4 
C14-0-(C14) H H + - - 
Cl4 P H + + + + f - 
c14-o-(C14) P I-J + + + + + Ik 
C12-OH P Cl4 + - - 
C14-OH P Cl4 + - - 
Control 
None 
Lipid A 
+ - 
+ + + f 
a LAL: Limulus amoebocyte lysate 
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Table 2 
Interferon-inducing activity of synthetic lipid A analogues 
February 1984 
Compound 
no. 
Substituent 
4-O- 6-O- 
(Rz) (R3) 
Experiment 
no. 
Units of interferon induced at the concentration 
(.ug/ml) of 
10 1.0 10-l 1o-2 lo-’ 1o-4 
2 Cl4 
3 c14-o-(Cl41 
4 C12-OH 
5 C14-OH 
Control None 
Lipid A 
H H 1 12 cl0 <lO 
2 <lO cl0 <lO 
3 cl0 Cl0 <lO 
P H 1 < 10 cl0 <lO 
2 c 10 cl0 cl0 
3 < 10 <lO cl0 
P H 1 213 97 cl0 
2 90 28 Cl0 
3 190 113 19 
P Cl4 4 cl0 <lO <lO 
P Cl4 4 < 10 <lO < 10 
1 cl0 <lO 
2 <lO cl0 
3 cl0 Cl0 
4 <lO cl0 
1 427 22 <lO cl0 
2 200 130 48 Cl0 
3 605 390 26 cl0 
I 4 154 23 cl0 cl0 
horseshoe crab activation: the activity of com- 
pound 3 was the same as that of r&Ural lipid A 
and that of compound 2 was one order less. No 
such activity was detqcted in the other 3 com- 
pounds. Three preparations each of compounds 1, 
2 and 3 were subjected to this assay and similar 
results were obtained. 
Interferon-inducing activity was found clearly 
only in compound 3, as shown in table 2. The ac- 
tivity is fairly strong, but the minimal effective 
concentration was 2-3 orders of magnitude higher 
than that of natural lipid A. 
Pyrogenicity of compounds l-3 was tested using 
rabbits. No activity was detected in any of the 3 
compounds at 30 /cg/kg, the highest dose 
examined. 
TNF-inducing activity of compounds l-3 was 
also tested. As shown in table 3, compound 3 ex- 
pressed relatively strong activity, compound 2 
showed weak but significant activity, and com- 
pound 1 showed no activity at all. 
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4. DISCUSSION 
Three out of 4 biological activities described 
above were significantly expressed by one of the 
synthetic lipid A analogues (compound 3). This 
compound is a derivative of 3-O-tetradecanoyl-D- 
glucosamine possessing 4-0-phosphoryl and N- 
tetradecanoyloxytetradecanoyl groups. Com- 
pound 1, which is a nonphosphorylated erivative 
of compound 3, showed none of those activities. 
This clearly indicates the importance of the 4-0- 
phosphoryl group for expression of these 
activities. 
Comparing the activities of compounds 2 and 3, 
the activity of proclotting enzyme of horseshoe 
crab activation of both compounds was as strong 
as that of natural lipid A, although that of com- 
pound 2 was one order of magnitude less than that 
of compound 3. As for TNF-inducing activity, 
compound 3 expressed relatively strong activity, 
but the activity in compound 2 was weak. Inter- 
February 1984 Volume 167, number 2 FEBS LETTERS 
Table 3 
Tumor necrosis factor (TNF)-inducing activity of synthetic lipid A analogues 
Compound 
no. 
Substituent 
4-0- 
CR21 
6-0- 
(R3) 
Activity of induced TNF on L-929 cells 
Growth inhibition Cytocidal effect 
(t3H]TdR uptake)’ (s@ (dead/viable)’ (O~O)~ 
1 c14-o-(Cl41 H H 31 767 f 1 039 5.5 7/140 4.8 
2 Cl4 P H 24 968*1 007 26.0* 22/100 18.0* 
3 c14-o-((214) P H 6513~t 763 80.4** 69/22 77.5** 
Control None 32 999&l 124 1.9 6/160 3.6 
Lipid A 1 457* 273 95.7** 60/2 96.7** 
a Mean cpm f SE in triplicate; b % Growth inhibition = [l - (cpm in a test serum)/(cpm in a control without 
serum)] x 100; ’ x 104 cells/ml, viable and dead cells were determined using phase microscopy; d 070 Cytocidal effect 
= (number ‘of dead cells/number of total cells) x 100 
* PcO.01, ** P<O.OOl 
feron-inducing activity was clearly shown by com- 
pound 3 but the activity in compound 2 was un- 
detectable. Compound 2 is a derivative of com- 
pound 3 which possesses the Cl4 group as the N- 
acyl group instead of the C14-0-(C14) group in 
compound 3. The results indicate that not only the 
4-O-phosphoryl group but also the N-acyl group 
contribute largely to the expression of TNF- and 
interferon-induction activities: the C14-0-(C14) 
group is a much more effective N-acyl substituent 
than the Cl4 group. 
Compounds 4 and 5 are derivatives of com- 
pound 3 which possess additional 6-O-tetra- 
decanoyl groups and altered N-acyl groups such as 
a Clz-OH group (compound 4) or a C14-OH group 
(compound 5). These compounds expressed 
neither proclotting enzyme of horseshoe crab ac- 
tivation nor interferon-inducing activities even 
though they possess the 4-0-phosphoryl group. In 
our previous study [5,6] it was shown that not only 
the C14-0-(C14) group but the C14-OH group is 
also a more effective substituent than the Cl4 
group as the N-acyl group of glucosamine disac- 
charide derivatives of synthetic lipid A analogues. 
Judging from these results it is suggested that the 
6-O-acylation prevents or reduces the expression of, 
these activities. 
As described above,. all the biological activities 
tested are significantly expressed by compound 3. 
This compound fulfills nearly completely the struc- 
ture requirement of the nonreducing sugar moiety 
of the revised structure of lipid A which has been 
proposed recently [8,9]. This result is a strong in- 
dication that several biological activities of the en- 
dotoxin can be clearly expressed solely by the 
structure of the nonreducing sugar moiety of lipid 
A. 
ACKNOWLEDGEMENT 
This work was supported in part by a grant-in- 
aid for scientific research of the Japanese Ministry 
of Education, 1983. 
REFERENCES 
PI 
[iI 
131 
[41 
151 
161 
Galanos, C., Liideritz, O., Rietschel, E.T. and 
Westphal, 0. (1977) Int. Rev. Biochem. 14, 
239-335. 
Liideritz, O., Galanos, C., Lehmann, V., Mayer, 
H., Rietschel, E.T. and Weckesser, J. (1978) Na- 
turwissenschaften 65, 578-585. 
Inage, M., Chaki, H., Kusumoto, S. and Shiba, T. 
(1980) Tetrahedron Lett. 21, 3889-3892. 
Kiso, M., Nishiguchi, H., Murase, S. and 
Hasegawa, A. (1981) Carbohydr. Res. 88, CS-C9. 
Matsuura, M., Kojima, Y., Homma, J.Y., Kubota, 
Y., Shibukawa, N., Shibata, M., Inage, M., 
Kusumoto, S. and Shiba, T. (1983) Eur. J. 
Biochem., in press. 
Kumazawa, Y., Matsuura, M., Nakatsuru- 
Watanabe, Y., Fukumoto, M., Nishimura, C., 
Homma, J.Y., Inage, M., Kusumoto, S. and 
Shiba, T. (1983) Eur. J. Immunol., in press. 
229 
Volume 167, number 2 FEBS LETTERS February 1984 
[7] Yasuda, T., Kanegasaki, S., Tsumita, T., 
Tadakuma, T., Homma, J.Y., Inage, M., 
Kusumoto, S. and Shiba, T. (1982) Eur. J. Bio- 
them. 124, 405-407. 
[8] Takayama, K., Qureshi, N., Mascagni, P., 
Nashed, M.A., Anderson, L. and Raetz, C.R.H. 
(1983) J. Biol. Chem. 258, 7379-7385. 
[9] Imoto, M., Kusumoto, S., Shiba, T., Naoki, H., 
Iwashita, T., Rietschel, E.T., Wollenweber, H.- 
W., Galanos, C. and Ltideritz, 0. (1983) Tetra- 
hedron Lett. 24, 4017-4020. 
[lo] Kiso, M., Ishida, H. and Hasegawa, A. (1984) 
Agric. Biol. Chem. 48, 251-252. 
[l l] Kiso, M. and Hasegawa, A. (1984) in: Bacterial 
Endotoxin (Westphal, 0. et al. eds) Verlag Che- 
miePhysik Verlag, Weinheim, in press. 
[ 121 Car-swell, E.A., Old, L. J., Kassel, R.L., Green, S., 
Fiore, N. and Williamson, B. (1975) Proc. Natl. 
Acad. Sci. USA 72, 3666-3670. 
[13] Green, S., Dobrjansky, A., Chiasson, M.A., 
Carswell, E., Schwartz, M.K. and Old, L. J. (1977) 
J. Natl. Cancer Inst. 59, 1519-1522. 
230 
